Temperament, character and serotonin activity in the human brain: A positron emission tomography study based on a general population cohort

Psychological Medicine

Volumn 43, Issue 4, 2013, Pages 881-894

  Tuominen, L ^a,b   Salo, J ^c   Hirvonen, J ^a,b   Nagren, K ^d   Laine, P ^a   Melartin, T ^c   Isometsa, E ^c   Viikari, J ^b   Cloninger, C R ^e   Raitakari, O ^f   Hietala, J ^a,b   Keltikangas Jarvinen, L ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TURKU   (Finland)

Author keywords

healthy volunteers; Key words Harm avoidance; neuroimaging; personality; positron emission tomography; serotonin; serotonin transporter

Indexed keywords

BENZYLAMINE DERIVATIVE; CARBON; DIAGNOSTIC AGENT; N,N DIMETHYL 2 (2 AMINO 4 METHYLPHENYLTHIO)BENZYLAMINE; N,N-DIMETHYL-2-(2-AMINO-4-METHYLPHENYLTHIO)BENZYLAMINE; RADIOPHARMACEUTICAL AGENT; SEROTONIN TRANSPORTER;

ADAPTIVE BEHAVIOR; ANALYSIS OF VARIANCE; ARTICLE; BRAIN; BRAIN MAPPING; CHARACTER; COHORT ANALYSIS; FEMALE; FINLAND; HUMAN; IMAGE PROCESSING; MALE; METABOLISM; METHODOLOGY; PERSONALITY TEST; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROTEIN BINDING; PSYCHOLOGICAL MODEL; REGRESSION ANALYSIS; SCINTISCANNING; SELF CONCEPT; TEMPERAMENT;

ADAPTATION, PSYCHOLOGICAL; ANALYSIS OF VARIANCE; BENZYLAMINES; BRAIN; BRAIN MAPPING; CARBON RADIOISOTOPES; CHARACTER; COHORT STUDIES; FEMALE; FINLAND; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MODELS, PSYCHOLOGICAL; PERSONALITY INVENTORY; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RADIOPHARMACEUTICALS; REGRESSION ANALYSIS; SELF EFFICACY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TEMPERAMENT;

EID: 84874927133     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S003329171200164X     Document Type: Article

References (85)

1. Agosti V, McGrath PJ (2002). Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression. Journal of Affective Disorders 71, 113-120.
2. Akerblom HK, Viikari J, Uhari M, Rasaaen L, Byckling T, Louhivuori K, Pesonen E, Suoninen P, Pietikainen M, Lahde PL, Dahl M, Aromaa A, Sarna S, PyoralaK (1985). Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross-sectional study of 1980, and an account of the children's and families' state of health. Acta Paediatrica Scandinavica (Suppl.) 318, 49-63.
3. Allgulander C, Cloninger CR, Przybeck TR, Brandt L (1998). Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorder. Psychopharmacology Bulletin 34, 165-166.
4. Allport G (1937). Personality: A Psychological Interpretation. Henry Holt and Company: New York.
5. Ando J, Ono Y, Yoshimura K, Onoda N, Shinohara M, Kanba S, Asai M (2002). The genetic structure of Cloninger's seven-factor model of temperament and character in a Japanese sample. Journal of Personality 70, 583-609.
6. Ando J, Suzuki A, Yamagata S, Kijima N, Maekawa H, Ono Y, Jang KL (2004). Genetic and environmental structure of Cloninger's temperament and character dimensions. Journal of Personality Disorders 18, 379-393.
7. Ball S, Tennen H, Kranzler H (1999). Factor replicability and validity of the Temperament and Character Inventory in substance-dependence patients. Psychological Assessment 11, 514-524.
8. Banki CM, Arato M (1983). Amine metabolites, neuroendocrine findings, and personality dimensions as correlates of suicidal behavior. Psychiatry Research 10, 253-261.
9. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, Lesch KP (1998). Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (' Ecstasy') in serotonin transporter-deficient mice. Molecular Pharmacology 53, 649-655.
10. Bhagwagar Z, Murthy N, Selvaraj S, Hinz R, Taylor M, Fancy S, Grasby P, Cowen P (2007). 5-HTT binding in recovered depressed patients and healthy volunteers: A positron emission tomography study with [11C]DASB. American Journal of Psychiatry 164, 1858-1865.
11. Black KJ, Sheline YI (1997). Personality disorder scores improve with effective pharmacotherapy of depression. Journal of Affective Disorders 43, 11-18.
12. Block J (1995). A contrarian view of the 5-factor approach to personality description. Psychological Bulletin 117, 187-215.
13. Borg J, Andree B, Soderstrom H, Farde L (2003). The serotonin system and spiritual experiences. American Journal of Psychiatry 160, 1965-1969.
14. Boz C, Gazioglu S, Altunayoglu V, Hocaoglu C (2007). Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache. Psychiatry and Clinical Neurosciences 61, 534-542.
15. Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK, Klaver JM, Charney DS, Manji HK, Drevets WC (2006). Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biological Psychiatry 60, 207-217.
16. Cannon DM, Ichise M, Rollis D, Klaver JM, Gandhi SK, Charney DS, Manji HK, Drevets WC (2007). Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biological Psychiatry 62, 870-877.
17. Cloninger CR (1986). A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatric Developments 4, 167-226.
18. Cloninger CR (1987). A systematic method for clinical description and classification of personality variants. A proposal. Archives of General Psychiatry 44, 573-588.
19. Cloninger CR (2004). Feeling Good: The Science of Well-Being. Oxford University Press, Inc.: New York.
20. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD (1994). The Temperament and Character Inventory (TCI): A Guide to its Development and Use. Center for Psychobiology of Personality, Washington University: St Louis.
21. Cloninger CR, Svrakic DM, Przybeck TR (1993). A psychobiological model of temperament and character. Archives of General Psychiatry 50, 975-990.
22. Cloninger CR, Svrakic DM, Przybeck TR (2006). Can personality assessment predict future depression? A twelve-month follow-up of 631 subjects. Journal of Affective Disorders 92, 35-44.
23. Cloninger CR, Zohar A, Cloninger K (2010). Promotion of well-being in person-centered mental health care. Focus 8, 199-215.
24. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, Mann MB, Dietz G, Saucier G, MacMurray JP (2000). A multivariate analysis of 59 candidate genes in personality traits: The temperament and character inventory. Clinical Genetics 58, 375-385.
25. Curtin F, Walker J, Peyrin L, Soulier V, Badan M, Schulz P (1997). Reward dependence is positively related to urinary monoamines in normal men. Biological Psychiatry 42, 275-281.
26. De Fruyt F, Van De Wiele L, Van Heeringen C (2000). Cloninger's psychobiological model of temperament and character and the five-factor model of personality. Personality and Individual Differences 29, 441-452.
27. de Winter RFP, Wolterbeek R, Spinhoven P, Zitman FG, Goekoop JG (2007). Character and temperament in major depressive disorder and a highly anxious-retarded subtype derived from melancholia. Comprehensive Psychiatry 48, 426-435.
28. Drevets WC, Bogers W, Raichle ME (2002). Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European Neuropsychopharmacology 12, 527-544.
29. Farmer A, Mahmood A, Redman K, Harris T, Sadler S, McGuffin P (2003). A sib-pair study of the Temperament and Character Inventory scales in major depression. Archives of General Psychiatry 60, 490-496.
30. Farmer RF, Seeley JR (2009). Temperament and character predictors of depressed mood over a 4-year interval. Depression and Anxiety 26, 371-381.
31. Finnema SJ, Varrone A, Hwang TJ, Gulyas B, Pierson ME, Halldin C, Farde L (2010). Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain. Synapse 64, 573-577.
32. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith C, Frackowiak RSJ (1995). Statistical parametric maps in functional imaging: A general linear approach. Human Brain Mapping 2, 189-210.
33. Frokjaer VG, Mortensen EL, Nielsen FA, Haugbol S, Pinborg LH, Adams KH, Svarer C, Hasselbalch SG, Holm S, Paulson OB, Knudsen GM (2008). Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biological Psychiatry 63, 569-576.
34. Gana K, Trouillet R (2003). Structure invariance of the Temperament and Character Inventory (TCI). Personality and Individual Differences 35, 1483-1495.
35. Gerra G, Zaimovic A, Timpano M, Zambelli U, Delsignore R, Brambilla F (2000). Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology 25, 479-496.
36. Gillespie NA, Cloninger CR, Heath AC, Martin NG (2003). The genetic and environmental relationship between Cloninger's dimensions of temperament and character. Personality and Individual Differences 35, 1931-1946.
37. Gutierrez F, Sangorrin J, Martin-Santos R, Torres X, Torrens M (2002). Measuring the core features of personality disorders in substance abusers using the Temperament and Character Inventory (TCI). Journal of Personality Disorders 16, 344-359.
38. Halldin C, Lundberg J, Sovago J, Gulyas B, Guilloteau D, Vercouillie J, Emond P, Chalon S, Tarkiainen J, Hiltunen J, Farde L (2005). [11C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET. Synapse 58, 173-183.
39. Herbst J, Zonderman A, McCrae R, Costa P (2000). Do the dimensions of the temperament and character inventory map a simple genetic architecture? Evidence from molecular genetics and factor analysis. American Journal of Psychiatry 157, 1285-1290.
40. Hirano S, Sato T, Narita T, Kusunoki K, Ozaki N, Kimura S, Takahashi T, Sakado K, Uehara T (2002). Evaluating the state dependency of the Temperament and Character Inventory dimensions in patients with major depression: A methodological contribution. Journal of Affective Disorders 69, 31-38.
41. Hirvonen J, Johansson J, Teras M, Oikonen V, Lumme V, Virsu P, Roivainen A, Na?gren K, Halldin C, Farde L, Hietala J (2008). Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility. Journal of Cerebral Blood Flow and Metabolism 28, 1059-1069.
42. Hirvonen J, van Erp TG, Huttunen J, Aalto S, Na?gren K, Huttunen M, Lonnqvist J, Kaprio J, Hietala J, Cannon TD (2005). Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Archives of General Psychiatry 62, 371-378.
43. Hornung JP (2003). The human raphe nuclei and the serotonergic system. Journal of Chemical Neuroanatomy 26, 331-343.
44. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007). Consensus nomenclature for in vivo imaging of reversibly binding radioligands. Journal of Cerebral Blood Flow and Metabolism 27, 1533-1539.
45. Isen JD, Baker LA, Raine A, Bezdjian S (2009). Genetic and environmental influences on the junior temperament and character inventory in a preadolescent twin sample. Behavior Genetics 39, 36-47.
46. Jokela M, Keltikangas-Jarvinen L (2011). The association between low socioeconomic status and depressive symptoms depends on temperament and personality traits. Personality and Individual Differences 51, 302-308.
47. Jovanovic H, Lundberg J, Karlsson P, Cerin A, Saijo T, Varrone A, Halldin C, Nordstrom AL (2008). Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. NeuroImage 39, 1408-1419.
48. Joyce PR, Mulder RT, Luty SE, McKenzie JM, Sullivan PF, Cloninger RC (2003). Borderline personality disorder in major depression: symptomatology, temperament, character, differential drug response, and 6-month outcome. Comprehensive Psychiatry 44, 35-43.
49. Kalueff AV, Olivier JD, Nonkes LJ, Homberg JR (2010). Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neuroscience and Biobehavioral Reviews 34, 373-386.
50. Karlsson H, Hirvonen J, Salminen JK, Hietala J (2009). No association between serotonin 5-HT1A receptors and spirituality among patients with major depressive disorders or healthy volunteers. Molecular Psychiatry 16, 282-285.
51. Keltikangas-Jarvinen L, Ravaja N, Viikari J (1999). Identifying Cloninger's temperament profiles as related to the early development of the metabolic cardiovascular syndrome in young men. Arteriosclerosis, Thrombosis, and Vascular Biology 19, 1998-2006.
52. Kim J, Son Y, Kim H, Lee S, Cho S, Kim Y, Cho ZH (2011). Association of harm avoidance with dopamine D2/3 receptor availability in striatal subdivisions: A high resolution PET study. Biological Psychology 87, 164-167.
53. Lammertsma AA, Hume SP (1996). Simplified reference tissue model for PET receptor studies. NeuroImage 4, 153-158.
54. Larsen P, Ulin J, Dahlstrøm K, JensenM(1997). Synthesis of [11C]iodomethane by iodination of [11C]methane. Applied Radiation and Isotopes 48, 153-157.
55. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531.
56. Limson R, Goldman D, Roy A, Lamparski D, Ravitz B, Adinoff B, Linnoila M (1991). Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls. Archives of General Psychiatry 48, 437-441.
57. Lundberg J, Halldin C, Farde L (2006). Measurement of serotonin transporter binding with PET and [11C]MADAM: A test-retest reproducibility study. Synapse 60, 256-263.
58. Lundberg J, Odano I, Olsson H, Halldin C, Farde L (2005). Quantification of 11C-MADAM binding to the serotonin transporter in the human brain. Journal of Nuclear Medicine 46, 1505-1515.
59. Mazza M, Mazza O, Pomponi M, Di Nicola M, Padua L, Vicini M, Bria P, Mazza S (2009). What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia? Comprehensive Psychiatry 50, 240-244.
60. Meyer JH (2007). Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. Journal of Psychiatry and Neuroscience 32, 86-102.
61. Miettunen J, Raevuori A (2012). A meta-analysis of temperament in Axis I psychiatric disorders. Comprehensive Psychiatry 53, 152-166.
62. Minaya O, FresanA(2009). Anxiety disorders comorbidity in first-episode depressed patients: personality differences based on the temperament and character inventory. Personality and Individual Differences 47, 522-526.
63. Moresco FM, Dieci M, Vita A, Messa C, Gobbo C, Galli L, Rizzo G, Panzacchi A, De Peri L, Invernizzi G, Fazio F (2002). In vivo serotonin 5HT2A receptor binding and personality traits in healthy subjects: A positron emission tomography study. NeuroImage 17, 1470-1478.
64. Munafo' MR, Freimer NB, Ng W, Ophoff R, Veijola J, Miettunen J, Jarvelin MR, Taanila A, Flint J (2009). 5-HTTLPR genotype and anxiety-related personality traits: A meta-analysis and new data. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 150B, 271-281.
65. Na?gren K, Truong P, Helin S, Amir A, Halldin C (2003). Experience from two systems for recirculating production of [11C]methyl iodide from target produced [11C]methane. Journal of Labelled Compounds and Radiopharmaceuticals 46 (Suppl. 1), S76.
66. Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K, Matsuzaki H, Suda S, Sugiyama T, Takei N, Mori N (2010). Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Archives of General Psychiatry 67, 59-68.
67. Parsey RV, Hastings RS, Oquendo MA, Huang YY, Simpson N, Arcement J, Huang Y, Ogden RT, Van Heertum RL, Arango V, Mann JJ (2006). Lower serotonin transporter binding potential in the human brain during major depressive episodes. American Journal of Psychiatry 163, 52-58.
68. Peirson AR, Heuchert JW, Thomala L, Berk M, Plein H, Cloninger CR (1999). Relationship between serotonin and the temperament and character inventory. Psychiatry Research 89, 29-37.
69. Pfohl B, Black D, Noyes Jr R, Kelley M, Blum N (1990). A test of the tridimensional personality theory: association with diagnosis and platelet imipramine binding in obsessive-compulsive disorder. Biological Psychiatry 28, 41-46.
70. Praschak-Rieder N, Wilson AA, Hussey D, Carella A, Wei C, Ginovart N, Schwarz MJ, Zach J, Houle S, Meyer JH (2005). Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biological Psychiatry 58, 825-830.
71. Rabiner EA, Messa C, Sargent PA, Husted-Kjaer K, Montgomery A, Lawrence AD, Bench CJ, Gunn RN, Cowen P, Grasby PM (2002). A database of [11C]WAY-100635 binding to 5-HT1A receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables. NeuroImage 15, 620-632.
72. Rahmim A, Cheng JC, Blinder S, Camborde ML, Sossi V (2005). Statistical dynamic image reconstruction in state-ofthe-art high-resolution PET. Physics in Medicine and Biology 50, 4887-4912.
73. Raitakari OT, Juonala M, Ronnemaa T, Keltikangas-Jarvinen L, Rasanen L, Pietikainen M, Hutri-Kahonen N, Taittonen L, Jokinen E, Marniemi J, Jula A, Telama R, Kahonen M, Lehtimaki T, Akerblom HK, Viikari JS (2008). Cohort profile: The Cardiovascular Risk in Young Finns Study. International Journal of Epidemiology 37, 1220-1226.
74. Reimold M, Batra A, Knobel A, Smolka MN, Zimmer A, Mann K, Solbach C, Reischl G, Schwarzler F, Grunder G, Machulla HJ, Bares R, Heinz A (2008). Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: A [11C]DASB PET study. Molecular Psychiatry 13, 606-613, 557.
75. Schinka JA, Busch RM, Robichaux-Keene N (2004). A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Molecular Psychiatry 9, 197-202.
76. Selvaraj S, Venkatesha Murthy N, Bhagwagar Z, Bose SK, Hinz R, Grasby PM, Cowen PJ (2011). Diminished brain 5-HT transporter binding in major depression: A positron emission tomography study with [11C]DASB. Psychopharmacology 213, 555-562.
77. Sen S, Burmeister M, Ghosh D (2004). Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 127B, 85-89.
78. Smith DJ, Duffy L, Stewart ME, Muir WJ, Blackwood DH (2005). High harm avoidance and low self-directedness in euthymic young adults with recurrent, early-onset depression. Journal of Affective Disorders 87, 83-89.
79. Sur C, Betz H, Schloss P (1996). Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience 73, 217-231.
80. Svrakic DM, Whitehead C, Przybeck TR, Cloninger CR (1993). Differential diagnosis of personality disorders by the seven-factor model of temperament and character. Archives of General Psychiatry 50, 991-999.
81. Talbot PS, Frankle WG, Hwang DR, Huang Y, Suckow RF, Slifstein M, Abi-Dargham A, Laruelle M (2005). Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans. Synapse 55, 164-175.
82. Van Dyck CH, Malison RT, Seibyl JP, Laruelle M, Klumpp H, Zoghbi SS, Baldwin RM, Innis RB (2000). Age-related decline in central serotonin transporter availability with [123I]b-CIT SPECT. Neurobiology of Aging 21, 497-501.
83. Van Heeringen C, Audenaert K, Van Laere K, Dumont F, Slegers G, Mertens J, Dierckx RA (2003). Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. Journal of Affective Disorders 74, 149-158.
84. Wachleski C, Salum GA, Blaya C, Kipper L, Paludo A, Salgado AP, Manfro GG (2008). Harm avoidance and self-directedness as essential features of panic disorder patients. Comprehensive Psychiatry 49, 476-481.
85. Wellman CL, Izquierdo A, Garrett JE, Martin KP, Carroll J, Millstein R, Lesch KP, Murphy DL, Holmes A (2007). Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. Journal of Neuroscience 27, 684-691.